Literature DB >> 2851105

Kinetic evidence for a common binding site for substrates and inhibitors of the neuronal noradrenaline carrier.

E Schömig1, M Körber, H Bönisch.   

Abstract

The neuronal noradrenaline uptake mechanism (uptake1) has been further characterized. For a number of substrates of uptake1 the half-saturating concentration (Km) and the maximal initial transport rate (Vmax) were determined. Furthermore, the dissociation constants (KD) for binding of these substrates to the desipramine binding site of the neuronal noradrenaline carrier were measured. The uptake experiments were done on rat phaeochromocytoma cells (PC12 cells), the binding experiments on purified plasma membranes of PC12 cells. The substrates differed markedly in respect of Vmax, Km, and KD. Neither Km and Vmax nor KD and Vmax were found to be correlated. However, the discrepancy between Km and KD expressed as the ratio, Km/KD, was negatively correlated with Vmax (r = -0.9315, n = 7, p less than 0.01). For the interpretation of these results a model on the basis of the steady-state assumption has been proposed for uptake1. From the mathematics of that model the following conclusions can be drawn. (1) The half-saturating substrate concentration (Km) is not identical with the dissociation constant for the binding of a substrate to the substrate recognition site (KD). (2) The discrepancy between Km and KD is expected to be negatively correlated with the maximal initial transport rate of the substrate (Vmax). The experimental results are in good agreement with the proposed model for uptake1. Especially the negative correlation between Km/KD and Vmax supports the hypothesis that desipramine inhibits uptake1 via binding to the substrate recognition site of the neuronal noradrenaline carrier.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2851105     DOI: 10.1007/bf00175787

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  16 in total

1.  A simplified method of quantitating protein using the biuret and phenol reagents.

Authors:  S T Ohnishi; J K Barr
Journal:  Anal Biochem       Date:  1978-05       Impact factor: 3.365

2.  A major role for chloride in (3H)- noradrenaline transport by rat heart adrenergic nerves.

Authors:  S Sánchez-Armáss; F Orrego
Journal:  Life Sci       Date:  1977-06-01       Impact factor: 5.037

3.  Kinetic analysis of the interaction between noradrenaline and Na+ in neuronal uptake: kinetic evidence for CO-transport.

Authors:  S Sammet; K H Graefe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-11       Impact factor: 3.000

4.  High-affinity [3H]desipramine binding in the peripheral and central nervous system: a specific site associated with the neuronal uptake of noradrenaline.

Authors:  R Raisman; M Sette; C Pimoule; M Briley; S Z Langer
Journal:  Eur J Pharmacol       Date:  1982-03-12       Impact factor: 4.432

5.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

6.  Solubilization and characterization of the 3H-desipramine binding site of rat phaeochromocytoma cells (PC12-cells).

Authors:  E Schömig; H Bönisch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-12       Impact factor: 3.000

7.  Large-scale preparation of plasma membrane vesicles from PC-12 pheochromocytoma cells and their use in noradrenaline transport studies.

Authors:  R Harder; H Bönisch
Journal:  Biochim Biophys Acta       Date:  1984-08-08

8.  High-affinity binding of [3H]desipramine to rat brain: a presynaptic marker for noradrenergic uptake sites.

Authors:  M Rehavi; P Skolnick; M J Brownstein; S M Paul
Journal:  J Neurochem       Date:  1982-04       Impact factor: 5.372

9.  Characterization of [3H]desipramine binding associated with neuronal norepinephrine uptake sites in rat brain membranes.

Authors:  C M Lee; J A Javitch; S H Snyder
Journal:  J Neurosci       Date:  1982-10       Impact factor: 6.167

10.  The transport of (+)-amphetamine by the neuronal noradrenaline carrier.

Authors:  H Bönisch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-10       Impact factor: 3.000

View more
  15 in total

1.  Characterization of the [3H]-desipramine binding site of the bovine adrenomedullary plasma membrane.

Authors:  J Michael-Hepp; B Blum; H Bönisch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-08       Impact factor: 3.000

2.  Translocation of dopamine and binding of WIN 35,428 measured under identical conditions in cells expressing the cloned human dopamine transporter.

Authors:  M E Reith; C Xu; L Zhang; L L Coffey
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996 Aug-Sep       Impact factor: 3.000

3.  Comparison of characteristics of dopamine uptake and mazindol binding in mouse striatum.

Authors:  I Zimányi; A Lajtha; M E Reith
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-12       Impact factor: 3.000

4.  Inhibition of neuronal noradrenaline transport (uptake1) and desipramine binding by amiloride and ethylisopropylamiloride.

Authors:  E Schömig; J Michael-Hepp; C L Schönfeld
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-11       Impact factor: 3.000

5.  Role of the sigma receptor in the inhibition of [3H]-noradrenaline uptake in brain synaptosomes and adrenal chromaffin cells.

Authors:  C Rogers; S Lemaire
Journal:  Br J Pharmacol       Date:  1991-08       Impact factor: 8.739

6.  Dopamine and adrenaline, but not isoprenaline, are substrates for uptake and metabolism in isolated perfused lungs of rats.

Authors:  L J Bryan-Lluka; S R O'Donnell
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-07       Impact factor: 3.000

7.  Cocaine acts as an apparent competitive inhibitor at the outward-facing conformation of the human norepinephrine transporter: kinetic analysis of inward and outward transport.

Authors:  N Chen; J B Justice
Journal:  J Neurosci       Date:  1998-12-15       Impact factor: 6.167

8.  Bivalent phenethylamines as novel dopamine transporter inhibitors: evidence for multiple substrate-binding sites in a single transporter.

Authors:  Kyle C Schmitt; Sreeman Mamidyala; Swati Biswas; Aloke K Dutta; Maarten E A Reith
Journal:  J Neurochem       Date:  2010-01-12       Impact factor: 5.372

9.  Binding of [3H]mazindol to cardiac norepinephrine transporters: kinetic and equilibrium studies.

Authors:  David M Raffel; Wei Chen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-07-22       Impact factor: 3.000

10.  Inhibition of neuronal noradrenaline uptake (uptake1) and desipramine binding by N-ethylmaleimide (NEM).

Authors:  E Schömig; J Michael-Hepp; H Bönisch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-06       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.